Sodium Iodide Symporter (NIS)-Mediated Radionuclide (131I, 188Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene Delivery

Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer

(2010) Alan R. Penheiter et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

(2010) H Li et al.   CANCER GENE THERAPY

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

(2010) M. Hingorani et al.   CURRENT CANCER DRUG TARGETS

A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer

(2010) M A Trujillo et al.   GENE THERAPY

Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter

(2009) I. Peerlinck et al.   CLINICAL CANCER RESEARCH

The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer

(2008) Michael J. Willhauck et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Internal Radiotherapy of Liver Cancer with Rat Hepatocarcinoma-Intestine-Pancreas Gene as a Liver Tumor-Specific Promoter

(2008) Julie Hervé et al.   HUMAN GENE THERAPY